AXGN
Price:
$44.99
Market Cap:
$2.42B
AxoGen, Inc., along with its subsidiaries, specializes in creating and distributing medical devices for the surgical repair of injured or severed peripheral nerves. Their comprehensive product portfolio offers several innovative solutions. The Avance Nerve Graft is a ready-to-use, biologically active human nerve allograft designed to bridge gaps in severed nerves. This avoids the need for a second surgical site for tissue donation, thereby eliminating associated complications. For facilitating the gentle reconnection of severed peripheral nerves, the company offers the AxoGuard Nerve Connector, an extracellular matrix (ECM) derived from porcine submucosa. This same porcine submucosa ECM form...[Read more]
Industry
Medical - Devices
IPO Date
1986-12-17
Stock Exchange
NASDAQ
Ticker
AXGN
According to AxoGen, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 118.39. This represents a change of -432.29% compared to the average of -35.63 of the last 4 quarters.
The mean historical PE Ratio of AxoGen, Inc. over the last ten years is -40.87. The current 118.39 PE Ratio has changed -29068.42% with respect to the historical average. Over the past ten years (40 quarters), AXGN's PE Ratio was at its highest in in the December 2024 quarter at 412.00. The PE Ratio was at its lowest in in the June 2026 quarter at -384.92.
Average
-40.87
Median
-27.00
Minimum
-96.26
Maximum
-13.39
Discovering the peaks and valleys of AxoGen, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 435.03%
Maximum Annual PE Ratio = -13.39
Minimum Annual Increase = -62.70%
Minimum Annual PE Ratio = -96.26
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -96.26 | 34.35% |
| 2024 | -71.65 | 435.03% |
| 2023 | -13.39 | -7.41% |
| 2022 | -14.46 | 0.34% |
| 2021 | -14.42 | -51.68% |
| 2020 | -29.83 | 23.40% |
| 2019 | -24.18 | -29.00% |
| 2018 | -34.05 | -62.70% |
| 2017 | -91.29 | 376.74% |
| 2016 | -19.15 | 95.32% |
The current PE Ratio of AxoGen, Inc. (AXGN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-60.44
5-year avg
-42.04
10-year avg
-40.87
AxoGen, Inc.’s PE Ratio is greater than IRadimed Corporation (50.61), greater than InMode Ltd. (10.99), greater than Integra LifeSciences Holdings Corporation (-192.41), greater than Tandem Diabetes Care, Inc. (-13.97), greater than AdaptHealth Corp. (-4.12), greater than Claritev Corporation (-1.50), greater than OPKO Health, Inc. (-13.90), greater than LifeMD, Inc. (-9.29), greater than Sana Biotechnology, Inc. (-3.77), greater than Taysha Gene Therapies, Inc. (-16.71),
| Company | PE Ratio | Market cap |
|---|---|---|
| 50.61 | $1.18B | |
| 10.99 | $871.81M | |
| -192.41 | $1.38B | |
| -13.97 | $1.34B | |
| -4.12 | $942.17M | |
| -1.50 | $443.41M | |
| -13.90 | $988.88M | |
| -9.29 | $185.23M | |
| -3.77 | $975.80M | |
| -16.71 | $2.05B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AxoGen, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like AxoGen, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is AxoGen, Inc.'s PE Ratio?
How is the PE Ratio calculated for AxoGen, Inc. (AXGN)?
What is the highest PE Ratio for AxoGen, Inc. (AXGN)?
What is the 3-year average PE Ratio for AxoGen, Inc. (AXGN)?
What is the 5-year average PE Ratio for AxoGen, Inc. (AXGN)?
How does the current PE Ratio for AxoGen, Inc. (AXGN) compare to its historical average?